| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase |
Activity |
5.03 |
% |
10.1021/acs.jmedchem.0c01762 |
| Homo sapiens |
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase |
Activity |
95.0 |
% |
10.1021/acs.jmedchem.0c01762 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
46.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Km |
880000.0 |
nM |
10.1046/j.1523-1755.2000.00007.x |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-6.43 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
6.74 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Km |
372000.0 |
nM |
10.1046/j.1523-1755.2000.00007.x |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
141.3 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Activity |
nan |
None |
10.1016/s0167-4889(02)00187-8 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Activity |
nan |
None |
10.1074/jbc.275.6.4507 |
| Homo sapiens |
Solute carrier family 22 member 4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
None |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
400.0 |
pmol/min/mg |
10.1016/j.bmc.2019.07.012 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1152/ajprenal.00140.2003 |
| Homo sapiens |
Solute carrier family 22 member 6 |
FC |
3.5 |
None |
10.1124/dmd.111.042036 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
8800.0 |
nM |
10.1006/abio.2000.4633 |
| Homo sapiens |
Solute carrier family 22 member 6 |
IC50 |
127000.0 |
nM |
10.1046/j.1523-1755.2003.00710.x |
| Homo sapiens |
Solute carrier family 22 member 6 |
Jmax |
230.0 |
pmol/min |
10.1124/dmd.111.042036 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
6020.0 |
nM |
10.1016/j.bmc.2011.04.045 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
6020.0 |
nM |
10.1016/s0024-3205(01)01296-6 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
3900.0 |
nM |
None |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
4000.0 |
nM |
10.1124/mol.56.3.570 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
5000.0 |
nM |
10.1152/ajprenal.1999.276.2.f295 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
8500.0 |
nM |
10.1152/ajprenal.00140.2003 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
8900.0 |
nM |
10.1124/jpet.102.043455 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
9300.0 |
nM |
10.1152/ajprenal.1999.276.1.f122 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
15400.0 |
nM |
10.1681/asn.v113383 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
20000.0 |
nM |
10.1124/dmd.111.042036 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Km |
22000.0 |
nM |
10.1038/sj.bjp.0704482 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ratio |
11.0 |
uL/min |
10.1124/dmd.111.042036 |
| Homo sapiens |
Solute carrier family 22 member 7 |
Activity |
nan |
None |
10.1006/bbrc.2001.4774 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1006/bbrc.1998.9978 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1159/000074539 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
19600.0 |
nM |
10.1016/s0024-3205(01)01296-6 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Km |
87200.0 |
nM |
10.1124/mol.59.5.1277 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Activity |
nan |
None |
10.1211/0022357021440 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
30.1 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
82.43 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
23.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
94.72 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
27.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 3A1 |
Activity |
30.0 |
% |
10.1152/ajprenal.00402.2002 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Solute carrier family 22 member 20 |
Ki |
446000.0 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 20 |
Ki |
446683.59 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 20 |
Vmax |
4.6 |
pmol/hr |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
10.1124/mol.59.2.358 |
| Mus musculus |
Solute carrier family 22 member 6 |
Ki |
9332.54 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 6 |
Ki |
9400.0 |
nM |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 6 |
Km |
37300.0 |
nM |
10.1074/jbc.274.3.1519 |
| Mus musculus |
Solute carrier family 22 member 6 |
Vmax |
5.7 |
pmol/hr |
10.1074/jbc.m703467200 |
| Mus musculus |
Solute carrier family 22 member 7 |
Activity |
nan |
None |
10.1124/mol.62.1.7 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
14.2 |
% |
10.1124/jpet.103.063370 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
20.0 |
% |
10.1124/dmd.32.5.479 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1074/jbc.m203803200 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1124/dmd.32.5.479 |
| Mus musculus |
Solute carrier family 22 member 8 |
Activity |
nan |
None |
10.1124/jpet.103.063370 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9285.0 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
11689.1 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
nM |
10.1021/jm00125a017 |
| Rattus norvegicus |
Aldose reductase |
Inhibition |
22.0 |
% |
10.1021/jm00125a017 |
| Rattus norvegicus |
Monocarboxylate transporter 1 |
Activity |
nan |
None |
10.1211/0022357991776804 |
| Rattus norvegicus |
Peptidyl-glycine alpha-amidating monooxygenase |
Activity |
0.4 |
None |
10.1016/j.bmc.2008.10.013 |
| Rattus norvegicus |
Peptidyl-glycine alpha-amidating monooxygenase |
Km |
2600000.0 |
nM |
10.1016/j.bmc.2008.10.013 |
| Rattus norvegicus |
Peptidyl-glycine alpha-amidating monooxygenase |
Ratio |
2.2 |
10'3/M/s |
10.1016/j.bmc.2008.10.013 |
| Rattus norvegicus |
Peptidyl-glycine alpha-amidating monooxygenase |
Vmax(app) |
5.6 |
/s |
10.1016/j.bmc.2008.10.013 |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
Activity |
nan |
None |
10.1074/jbc.272.26.16548 |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
IC50 |
1300000.0 |
nM |
10.1152/ajprenal.2001.281.3.f454 |
| Rattus norvegicus |
Solute carrier family 22 member 2 |
IC50 |
4500000.0 |
nM |
10.1152/ajprenal.2001.281.3.f454 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1124/mol.60.5.1091 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Km |
14300.0 |
nM |
10.1074/jbc.272.30.18526 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Km |
31000.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Km |
43200.0 |
nM |
10.1046/j.1523-1755.1999.00789.x |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Km |
70000.0 |
nM |
10.1074/jbc.272.48.30088 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Km |
85100.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier family 22 member 7 |
Activity |
nan |
None |
10.1016/s0014-5793(98)00585-7 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Activity |
20.3 |
% |
10.1097/00004647-200304000-00007 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Ki |
301000.0 |
nM |
None |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Ki |
398000.0 |
nM |
10.1124/mol.61.5.982 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Ki |
1350000.0 |
nM |
10.1124/jpet.300.3.746 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
Km |
64700.0 |
nM |
10.1074/jbc.274.19.13675 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A1 |
Activity |
nan |
None |
10.1152/ajprenal.1996.270.2.f319 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Activity |
nan |
None |
10.1016/s0014-5793(99)01221-1 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A4 |
Activity |
nan |
None |
10.1007/s004240100697 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A5 |
Activity |
nan |
None |
10.1007/s004240100697 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1B2 |
Activity |
nan |
None |
10.1007/s004240100697 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.91 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.08913 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.2 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.54 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.2473 |
None |
10.1101/2020.04.03.023846 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.259 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1258.9 |
nM |
None |
| None |
Unchecked |
Inhibition_index |
260.0 |
None |
10.1021/jm00212a009 |
| None |
Unchecked |
Ratio |
7.0 |
None |
10.1016/j.bmc.2019.07.012 |
| None |
Unchecked |
Ratio pKi |
-1.68 |
None |
10.1074/jbc.m703467200 |